Clinical trial
The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients
NCT00119769 · Hvidovre University Hospital, Other · Completed
Key facts
| NCT number | NCT00119769 |
|---|---|
| Title | The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients |
| Official title | The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients on Highly Active Antiretroviral Therapy (HAART) |
| Lead sponsor | Hvidovre University Hospital, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections, Lipodystrophy |
| Intervention type | Drug |
| Interventions | Placebo, Genotropin (human recombinant Growth hormone) |
| Enrollment | 46 |
| Start date | Feb 1, 2005 |
| Primary completion | May 1, 2007 |
| Completion | Jul 1, 2008 |
| First posted | Jul 14, 2005 |
| Last update posted | Aug 27, 2008 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: